Germany · Delayed Price · Currency is EUR ETR:MED Statistics
Total Valuation
ETR:MED has a market cap or net worth of EUR 168.15 million. The enterprise value is 474.65 million.
| Market Cap | 168.15M |
| Enterprise Value | 474.65M |
Important Dates
The last earnings date was Monday, May 4, 2026.
| Earnings Date | May 4, 2026 |
| Ex-Dividend Date | May 29, 2026 |
Share Statistics
ETR:MED has 47.50 million shares outstanding. The number of shares has increased by 6.13% in one year.
| Current Share Class | 47.50M |
| Shares Outstanding | 47.50M |
| Shares Change (YoY) | +6.13% |
| Shares Change (QoQ) | +6.13% |
| Owned by Insiders (%) | n/a |
| Owned by Institutions (%) | 36.34% |
| Float | 11.44M |
Valuation Ratios
The trailing PE ratio is 6.12 and the forward PE ratio is 4.60.
| PE Ratio | 6.12 |
| Forward PE | 4.60 |
| PS Ratio | 0.21 |
| PB Ratio | 0.66 |
| P/TBV Ratio | 0.71 |
| P/FCF Ratio | 3.30 |
| P/OCF Ratio | 1.74 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 4.06, with an EV/FCF ratio of 9.32.
| EV / Earnings | 16.27 |
| EV / Sales | 0.59 |
| EV / EBITDA | 4.06 |
| EV / EBIT | 7.37 |
| EV / FCF | 9.32 |
Financial Position
The company has a current ratio of 1.74, with a Debt / Equity ratio of 1.52.
| Current Ratio | 1.74 |
| Quick Ratio | 1.09 |
| Debt / Equity | 1.52 |
| Debt / EBITDA | 3.29 |
| Debt / FCF | 7.54 |
| Interest Coverage | 3.20 |
Financial Efficiency
Return on equity (ROE) is 12.39% and return on invested capital (ROIC) is 8.51%.
| Return on Equity (ROE) | 12.39% |
| Return on Assets (ROA) | 4.63% |
| Return on Invested Capital (ROIC) | 8.51% |
| Return on Capital Employed (ROCE) | 9.61% |
| Weighted Average Cost of Capital (WACC) | 4.64% |
| Revenue Per Employee | 105,573 |
| Profits Per Employee | 3,801 |
| Employee Count | 7,677 |
| Asset Turnover | 0.94 |
| Inventory Turnover | 96.54 |
Taxes
In the past 12 months, ETR:MED has paid 10.38 million in taxes.
| Income Tax | 10.38M |
| Effective Tax Rate | 25.99% |
Stock Price Statistics
The stock price has increased by +20.41% in the last 52 weeks. The beta is 0.39, so ETR:MED's price volatility has been lower than the market average.
| Beta (5Y) | 0.39 |
| 52-Week Price Change | +20.41% |
| 50-Day Moving Average | 3.55 |
| 200-Day Moving Average | 3.45 |
| Relative Strength Index (RSI) | 52.53 |
| Average Volume (20 Days) | 10,064 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, ETR:MED had revenue of EUR 810.48 million and earned 29.18 million in profits. Earnings per share was 0.58.
| Revenue | 810.48M |
| Gross Profit | 171.63M |
| Operating Income | 64.25M |
| Pretax Income | 39.92M |
| Net Income | 29.18M |
| EBITDA | 86.69M |
| EBIT | 64.25M |
| Earnings Per Share (EPS) | 0.58 |
Balance Sheet
The company has 78.27 million in cash and 384.07 million in debt, with a net cash position of -305.80 million or -6.44 per share.
| Cash & Cash Equivalents | 78.27M |
| Total Debt | 384.07M |
| Net Cash | -305.80M |
| Net Cash Per Share | -6.44 |
| Equity (Book Value) | 253.17M |
| Book Value Per Share | 5.01 |
| Working Capital | 123.47M |
Cash Flow
In the last 12 months, operating cash flow was 96.41 million and capital expenditures -45.48 million, giving a free cash flow of 50.93 million.
| Operating Cash Flow | 96.41M |
| Capital Expenditures | -45.48M |
| Depreciation & Amortization | 22.44M |
| Net Borrowing | -77.35M |
| Free Cash Flow | 50.93M |
| FCF Per Share | 1.07 |
Margins
Gross margin is 21.18%, with operating and profit margins of 7.93% and 3.60%.
| Gross Margin | 21.18% |
| Operating Margin | 7.93% |
| Pretax Margin | 4.93% |
| Profit Margin | 3.60% |
| EBITDA Margin | 10.70% |
| EBIT Margin | 7.93% |
| FCF Margin | 6.28% |
Dividends & Yields
This stock pays an annual dividend of 0.04, which amounts to a dividend yield of 1.13%.
| Dividend Per Share | 0.04 |
| Dividend Yield | 1.13% |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | 6.51% |
| Buyback Yield | -6.13% |
| Shareholder Yield | -5.00% |
| Earnings Yield | 17.35% |
| FCF Yield | 30.29% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 7 |